NOVENTURE
UTIPRO® PLUS AF
Control and prevention of cystitis
What is Utipro® Plus AF
Utipro® Plus AF is a medical device based on xyloglucan and gelose. It acts mechanically in the intestinal lumen, impairing the contact of the pathogens with the intestinal mucosa, which is the first step for bacterial proliferation and their subsequent passage to the urinary tract.
Intended use
Utipro® Plus AF is intended for:
- The control and prevention of uncomplicated urinary tract infections (cystitis) produced by pathogens such as E. coli and other gram (-) bacteria normally involved in the aetiology of urological infections.
- The prevention of new episodes in case of recurrent urinary tract infections, generally caused by the intestinal bacteria reservoir.
It is to be taken orally, from the appearance of the first symptoms of urinary tract disorders, with the aim of reducing the proliferation rate of pathogens that may degenerate into infections.
Who is Utipro® Plus AF for
It is intended for use in adolescents aged 14 years and older and in adults.
Additional information
- Utipro® Plus AF is a substance-based medical device that holds EU MDR certification, Class III, issued by the NB CE 0476.
- No relevant side effects related to its use have been reported in clinical studies.
- It does not have bactericidal or bacteriostatic properties, therefore it cannot substitute antibiotic treatment when needed, but it can be administered concomitantly.
- It is mentioned in the guidelines of the European Association of Urologists (EAU) as the non-antibiotic approach to cystitis with the highest level of scientific evidence.
- Guidelines issued from the Swiss Society of Gynecology and Obstetrics (SSGO) mention Utipro® Plus AF among antibiotic-free approaches for recurrent cystitis.
Clinical studies and publications, as well as the Instructions for Use (IFU) and the Summary on Safety and Clinical Performance (SSCP), are available upon request.
